For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Lg Life Sciences, Limited

Calculating rank

USPTO Granted Patents = 75

% Expired Patents = 37.3

CIPO Patents = 17

EPO Patents = 21

Trademarks = 4

Forward Citations = 175

Loading Chart...

Loading Chart...

316 inventors (with patents filed for the assignee):

Koo Lee (10 out of 14 patents)

Heui Sul Park (8 out of 12 patents)

Soon Ha Kim (7 out of 11 patents)

4. Sung Bae Lee (7 out of 12 patents)

5. Hyoung Jin Kim (7 out of 11 patents)

6. Hyo Shin Kwak (6 out of 26 patents)

7. Sang Dae Lee (6 out of 8 patents)

8. Seung Hyun Yoon (6 out of 30 patents)

9. Sun Young Koo (5 out of 7 patents)

10. Dong Ook Seo (5 out of 5 patents)

11. Eok Park (5 out of 5 patents)

12. Dong Sup Shim (5 out of 5 patents)

13. Hyun-Ik Shin (5 out of 6 patents)

14. Sung Pil Choi (5 out of 11 patents)

15. Soo Yong Chung (5 out of 9 patents)

Core Competencies:

Wound Infection Prevention

Sphingosine-1-Phosphate

Receptor Agonists

Dipeptidyl Peptidase-IV

Xanthine Oxidase Inhibitors

Caspase Inhibitors

Melanocortin Agonists

Nucleoside Phosphonates

Drug-Drug Interactions

Thrombin Inhibitors

Gene Families

Microparticle Formulations

75 patents: Sort by Forward Citations

1. 11311420 - Apparatus for wound infection prevention (2022-04-26),

2. 10085892 - Apparatus and method for wound infection prevention (2018-10-02),

3. 9540362 - Sphingosine-1-phosphate receptor agonists, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent (2017-01-10),

4. 9492118 - Pre-treatment process for electrochemical amperometric sensor (2016-11-15),

5. 9447044 - Thioaryl derivatives as GPR120 agonists (2016-09-20),

6. 9234211 - Hybrid promoter and recombinant vector comprising the same (2016-01-12),

7. 9161981 - Non-aqueous oily injectable formulation exhibiting preservative efficacy (2015-10-20),

8. 9091720 - Detection system using magnetic resistance sensor (2015-07-28),

9. 9000028 - Indole and indazole compounds as an inhibitor of cellular necrosis (2015-04-07),

10. 8889691 - Indole compounds as an inhibitor of cellular necrosis (2014-11-18),

11. 8859567 - Hydrate of 1-{(2S)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di-hydropyrido[3,4-D]pyrimidin-7(6H)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate (2014-10-14),

12. 8741927 - Production method of intermediate compound for synthesizing medicament (2014-06-03),

13. 8729273 - Compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same (2014-05-20),

14. 8569307 - Indole compounds as an inhibitor of cellular necrosis (2013-10-29),

15. 8481537 - Caspase inhibitors based of pyridazinone scaffold (2013-07-09),

Company Overview

Lg Life Sciences, Limited, based in Seoul, South Korea, specializes in the development and manufacturing of pharmaceutical compositions. The company focuses on innovative solutions for wound infection prevention and leverages advanced technologies such as sphingosine-1-phosphate receptor agonists and dipeptidyl peptidase-IV inhibitors. Its research encompasses a range of therapeutic areas, including xanthine oxidase inhibitors, caspase inhibitors, melanocortin agonists, and nucleoside phosphonates, contributing to advancements in healthcare and treatment efficacy.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

75 Patents

#100 in Seoul

#236 in South Korea

#10,029 in the World

Seoul, South Korea

Lg Life Sciences, Limited

Forward Citations = 175

316 inventors:

Koo Lee (10 out of 14 patents)

Heui Sul Park (8 out of 12 patents)

Soon Ha Kim (7 out of 11 patents)

4. Sung Bae Lee (7 out of 12 patents)

5. Hyoung Jin Kim (7 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lg Life Sciences, Limited. Retrieved from https://idiyas.com/company/lg-life-sciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…